Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Mayapada Clinic Accomplished Plenary Level Certification from the Accreditation Commission of the Ministry of Health
2019-12-05 13:17
Biocon Biologics Takes Forward its Mission to Unlock Universal Access to Insulins Globally
2019-12-05 09:00
FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa
2019-12-04 19:22
Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China
2019-12-04 12:57
Continuing the Resplendence with 20 Years' Glory, CPhI China Welcomes the Golden Year of Chinese Pharma
2019-12-03 16:54
Innovent Biologics Announces FDA Acceptance of NDA for Pemigatinib in Patients with Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusions or Rearrangements
2019-12-02 08:00
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication
2019-11-29 20:22
Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout
2019-11-29 08:00
Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL)
2019-11-28 12:10
Mundipharma CEO Raman Singh Wins Executive of The Year at SBR Management Excellence Awards
2019-11-28 12:00
Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050
2019-11-28 00:34
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-PD-1/HER2 Bispecific Antibody in China
2019-11-27 07:50
New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease
2019-11-27 02:31
Japan and Singapore Grant CRISPR Patents to Merck
2019-11-26 21:00
Xinhua Silk Road: Er-Kang highly recognized for "going global" achievements in Cambodia
2019-11-25 18:16
Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050
2019-11-25 08:15
Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference
2019-11-25 07:00
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland
2019-11-23 01:55
Patient Enrollment Completed in Phase III Clinical Study of Adapalene-Clindamycin Combination Gel in China
2019-11-22 23:50
Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years
2019-11-21 23:05
1
185
186
187
188
189
247